Abstract RFLP haplotypes and common mutations in the phenylalanine hydroxylase gene have been studied in a group of 29 Bulgarian PKU families. Haplotype distribution differs from that in other European populations, with a predominance of haplotypes 2 and 6 and a total absence of haplotype 3. The amino acid substitutiou in codon 408 is the most frequent molecular defect. The splicing defect in intron 12 is not found in Bulgarian PKU patients. Testing for three mutations, reported to be common among haplotype 1 and 4 alleles, has shown that they occur less frequently ini Bulgarian PKU patients. Screening with five pairs of allele specific oligonucleotides failed to show the mutation in 590/o of the patients. These findings-add to the evidence that PKU is heterogeneous and that significant interpopulation differences exist. At present, DNA data cannot be used as an aid in early clinical classification and prognosis of hyperphenylalaninaemia in Bulgaria.
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Neonatal screening in Bulgaria, with nearly one million neonates tested, has shown an incidence of classical phenylketonuria (PKU) of 1 in 21 000 and a relatively high frequency of mild hyperphenylalaninaemia (HPA) with a PKU/HPA ratio of 1/2. Experience has shown that both parental anxiety and non-compliance with the diet are frequent problems which require prompt classification of the phenylalaninaemias detected by the screening.
Studies (GT-*AT).3 The presence of each mutation was tested after amplification of exons 5, 7, and 12 and the flanking intronic sequences in the PAH gene. PCR conditions were as described previously.'6 Dot blot hybridisation with 32p labelled allele specific oligonucleotides (ASO) was used to detect the presence of the mutations. 17 The sequences of the oligonucleotide probes were as described.3 4 1415 Previously studied patients of German origin,5 12 15 whose genotypes had been confirmed by direct sequencing, served as positive and negative controls.
Results

RFLP HAPLOTYPES
Haplotype assignment was possible in 25 out of 29 families. The RFLP data are shown in table 1. Seven different RFLP haplotypes were found in the group of mutant alleles. Haplotype 2 was the most common and occurred in 38% of mutant alleles. Second in frequency was haplotype 6 (22%), which was found mainly in patients of Turkish origin. These two The C to T transition in codon 408, resulting in a Trp for Arg substitution, was found to be the major molecular defect which occurred in 34% of all PKU alleles studied. This mutation was found in all haplotype 2 alleles and also in a single haplotype 5 chromosome.
The splicing defect in intron 12, which accounts for nearly 40%/ of HPA alleles in Denmark,3 was absent in Bulgarian PKU patients. This is in agreement with the absence of haplotype 3, which has been reported to be in tight linkage with the splicing mutation. 3 The missense mutation in exon Another missense mutation, the G to A transition in codon 261 (Arg-*Gln), was carried by two mutant chromosomes, both haplotype 1. Thus the mutation in codon 261 is similar in frequency to other European populations. 14 In vitro expression studies have shown Arg261Gln261 substitution were compound heterozygotes, for the common deifect in codon 408 in one case and for an unknown defect linked to haplotype 6 in the other. Although phenylalanine tolerance has not been established yet, both patients had high neonatal phenylalanine levels, a protein loading curve with sustained high phenylalanine levels, and residual PAH activity below 1%. Theamino acid substitutionin codon 281 (Pro--Leu) was detected in a single haplotype 1 chromosome. This defect has been reported to account for over 25% of mutant haplotype 1 alleles in the German population. 15 Discussion Both RFLP haplotypes and mutations in Bulgarian PKU patients differ in distribution from other Caucasian populations.
About 90% of the PKU alleles in northern European populations are confined to haplotypes 1 to 4,1 "7 whereas in Bulgarian PKU patients these haplotypes account for 64% of mutant alleles. The difference is mainly related to the total absence of haplotype 3, which is very common in Denmark' and gradually declines in frequency in the south and east of Europe. A significant proportion of PKU alleles in this study belong to haplotype 6. This polymorphic haplotype is almost absent in northern Europeans, but has been reported to occur frequently in Turkish PKU patients.'9 Haplotype 6 alleles accounted for about 30% ofchromosomes with an unknown mutation in this study. This haplotype is in linkage disequilibrium with the disease and may therefore be associated with a single molecular defect.
As in other Caucasian populations,' 57 haplotypes 1 and 4 were found to be relatively common in Bulgarian PKU patients. Screening for three mutations, which have been previously detected in Caucasian chromosomes of these haplotypes, failed to show the molecular defect responsible in nearly 70% of these alleles. The lack of linkage disequilibrium between these haplotypes and PKU is a consistent finding in all European populations. This fact and the existence of interpopulation differences shown in this study suggest that haplotypes 1 and 4 may be very heterogeneous, not only in terms ofclinical phenotype, but also in terms of molecular defects leading to classical PKU.
The present findings are further evidence of the heterogeneous molecular basis of phenylketonuria and suggest that various mechanisms might have played a role in its spread. Unlike the common mutations in codon 408 and in the 5' splicing site of intron 12, which probably spread through founder effect, mutations linked to haplotypes 1 and 4 can be expected to be heterogeneous and to vary between populations. This study also indicates that the use of molecular genetics as an aid to early clinical diagnosis is not feasible in Bulgarian PKU families at present. The use of five pairs of ASOs has shown both mutations in five out of 29 patients, four homozygous for the defect in codon 408 and one compound heterozygote (cod26l/cod408). If haplotype 6 is indeed associated with a single mutation, as suggested by the presence of linkage disequilibrium, the proportion of informative cases will increase when this mutation becomes known; two patientsin thepresent study arehaplotype 6 homozygotes and three are 2/6 compounds. In the meantime, haplotype 6 in the homozygous state or in combination with haplotype 2 can be tentatively regarded as indicative of classical PKU, especially in patients of Turkish origin.
Although PKU is a treatable condition, our experience has shown that the majority of families are interested in prenatal diagnosis in future pregnancies. Taking into account the limited number of cases where direct mutation detection is applicable (17% of families are fully informative and 45% are partially informative), RFLP analysis has to be regarded as the main diagnostic tool. Most PKU carriers are RFLP heterozygotes, which results in almost 90% of families being fully informative for fetal RFLP analysis. 
